John R Desjarlais1, Greg A Lazar. Show Affiliations » 1. Xencor, 111 W. Lemon Avenue, Monrovia, CA 91016, USA. jrd@xencor.com
Abstract
Mesh： See more » AnimalsDrug DesignDrug Industry/methodsDrug Industry/trendsFilgrastimGranulocyte Colony-Stimulating Factor/geneticsGranulocyte Colony-Stimulating Factor/metabolismGranulocyte Colony-Stimulating Factor/therapeutic useHumansNeutropenia/drug therapyNeutropenia/metabolismProtein C/geneticsProtein C/metabolismProtein C/therapeutic useProtein Engineering/methodsProteins/geneticsProteins/metabolismProteins/therapeutic useRecombinant Proteins/geneticsRecombinant Proteins/metabolismRecombinant Proteins/therapeutic useSepsis/drug therapyTechnology, Pharmaceutical/methodsTechnology, Pharmaceutical/trends
Substances： See more » Protein CProteinsRecombinant ProteinsGranulocyte Colony-Stimulating Factordrotrecogin alfa activatedFilgrastim
Year: 2003 PMID： 14512227 DOI： 10.1016/S0167-7799(03)00205-1
Source DB: PubMed Journal: Trends Biotechnol ISSN： 0167-7799 Impact factor: 19.536